Cargando…

GRP78 in lung cancer

Glucose-regulating protein 78 (GRP78) is a molecular chaperone in the endoplasmic reticulum (ER) that promotes folding and assembly of proteins, controls the quality of proteins, and regulates ER stress signaling through Ca(2+) binding to the ER. In tumors, GRP78 is often upregulated, acting as a ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Shengkai, Duan, Wenzhe, Liu, Wenwen, Zhang, Xinri, Wang, Qi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7981903/
https://www.ncbi.nlm.nih.gov/pubmed/33743739
http://dx.doi.org/10.1186/s12967-021-02786-6
_version_ 1783667608909774848
author Xia, Shengkai
Duan, Wenzhe
Liu, Wenwen
Zhang, Xinri
Wang, Qi
author_facet Xia, Shengkai
Duan, Wenzhe
Liu, Wenwen
Zhang, Xinri
Wang, Qi
author_sort Xia, Shengkai
collection PubMed
description Glucose-regulating protein 78 (GRP78) is a molecular chaperone in the endoplasmic reticulum (ER) that promotes folding and assembly of proteins, controls the quality of proteins, and regulates ER stress signaling through Ca(2+) binding to the ER. In tumors, GRP78 is often upregulated, acting as a central stress sensor that senses and adapts to changes in the tumor microenvironment, mediating ER stress of cancer cells under various stimulations of the microenvironment to trigger the folding protein response. Increasing evidence has shown that GRP78 is closely associated with the progression and poor prognosis of lung cancer, and plays an important role in the treatment of lung cancer. Herein, we reviewed for the first time the functions and mechanisms of GRP78 in the pathological processes of lung cancer, including tumorigenesis, apoptosis, autophagy, progression, and drug resistance, giving a comprehensive understanding of the function of GRP78 in lung cancer. In addition, we also discussed the potential role of GRP78 as a prognostic biomarker and therapeutic target for lung cancer, which is conducive to improving the assessment of lung cancer and the development of new therapeutic interventions.
format Online
Article
Text
id pubmed-7981903
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-79819032021-03-22 GRP78 in lung cancer Xia, Shengkai Duan, Wenzhe Liu, Wenwen Zhang, Xinri Wang, Qi J Transl Med Review Glucose-regulating protein 78 (GRP78) is a molecular chaperone in the endoplasmic reticulum (ER) that promotes folding and assembly of proteins, controls the quality of proteins, and regulates ER stress signaling through Ca(2+) binding to the ER. In tumors, GRP78 is often upregulated, acting as a central stress sensor that senses and adapts to changes in the tumor microenvironment, mediating ER stress of cancer cells under various stimulations of the microenvironment to trigger the folding protein response. Increasing evidence has shown that GRP78 is closely associated with the progression and poor prognosis of lung cancer, and plays an important role in the treatment of lung cancer. Herein, we reviewed for the first time the functions and mechanisms of GRP78 in the pathological processes of lung cancer, including tumorigenesis, apoptosis, autophagy, progression, and drug resistance, giving a comprehensive understanding of the function of GRP78 in lung cancer. In addition, we also discussed the potential role of GRP78 as a prognostic biomarker and therapeutic target for lung cancer, which is conducive to improving the assessment of lung cancer and the development of new therapeutic interventions. BioMed Central 2021-03-21 /pmc/articles/PMC7981903/ /pubmed/33743739 http://dx.doi.org/10.1186/s12967-021-02786-6 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Review
Xia, Shengkai
Duan, Wenzhe
Liu, Wenwen
Zhang, Xinri
Wang, Qi
GRP78 in lung cancer
title GRP78 in lung cancer
title_full GRP78 in lung cancer
title_fullStr GRP78 in lung cancer
title_full_unstemmed GRP78 in lung cancer
title_short GRP78 in lung cancer
title_sort grp78 in lung cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7981903/
https://www.ncbi.nlm.nih.gov/pubmed/33743739
http://dx.doi.org/10.1186/s12967-021-02786-6
work_keys_str_mv AT xiashengkai grp78inlungcancer
AT duanwenzhe grp78inlungcancer
AT liuwenwen grp78inlungcancer
AT zhangxinri grp78inlungcancer
AT wangqi grp78inlungcancer